Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
The latest update is out from Concord Healthcare Group Co., Ltd. Class H ( (HK:2453) ).
Concord Healthcare Group Co., Ltd. has established a Remuneration and Appraisal Committee under its Board of Directors to enhance its remuneration management policies and appraisal systems for directors and senior management. This move is aimed at ensuring a formal and transparent procedure for developing remuneration policies, which is expected to improve corporate governance and align the management’s remuneration with the company’s goals, potentially impacting stakeholder confidence positively.
The most recent analyst rating on (HK:2453) stock is a Sell with a HK$2.50 price target. To see the full list of analyst forecasts on Concord Healthcare Group Co., Ltd. Class H stock, see the HK:2453 Stock Forecast page.
More about Concord Healthcare Group Co., Ltd. Class H
Concord Healthcare Group Co., Ltd. is a joint stock company incorporated in the People’s Republic of China. It operates in the healthcare industry, focusing on the management and appraisal of directors and senior management through a structured remuneration and evaluation system. The company is listed on the Stock Exchange of Hong Kong Limited.
Average Trading Volume: 5,461,772
Technical Sentiment Signal: Sell
Current Market Cap: HK$2.04B
See more insights into 2453 stock on TipRanks’ Stock Analysis page.